tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NRBO Stock Latest News

NeuroBo Pharmaceuticals Completes Phase 2a Trial for MASH Drug
Company AnnouncementsNeuroBo Pharmaceuticals Completes Phase 2a Trial for MASH Drug
6d ago
8K
NRBO
NeuroBo Pharmaceuticals completes last patient visit in Phase 2a DA-1241 trial
PremiumThe Fly
NeuroBo Pharmaceuticals completes last patient visit in Phase 2a DA-1241 trial
6d ago
NRBO
NeuroBo Pharmaceuticals Unveils Updated Corporate Presentation
PremiumCompany Announcements
NeuroBo Pharmaceuticals Unveils Updated Corporate Presentation
1M ago
8K
NRBO
NeuroBo’s DA-1726 Shows Promise in Obesity Trial Phase 1
PremiumCompany Announcements
NeuroBo’s DA-1726 Shows Promise in Obesity Trial Phase 1
1M ago
8K
NRBO
NeuroBo Pharmaceuticals announces data from SAD Part 1 of trial of DA-1726
PremiumThe Fly
NeuroBo Pharmaceuticals announces data from SAD Part 1 of trial of DA-1726
1M ago
NRBO
NeuroBo Pharmaceuticals reports Q2 EPS ($1.85), consensus ($1.12)
PremiumThe FlyNeuroBo Pharmaceuticals reports Q2 EPS ($1.85), consensus ($1.12)
3M ago
NRBO
NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial
Premium
Company Announcements
NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial
3M ago
8K
NRBO
NeuroBo Pharmaceuticals completes enrollment in Phase 1 trial of DA-1726
Premium
The Fly
NeuroBo Pharmaceuticals completes enrollment in Phase 1 trial of DA-1726
3M ago
NRBO
Is NRBO a Buy, Before Earnings?
PremiumPre-Earnings
Is NRBO a Buy, Before Earnings?
3M ago
NRBO
NeuroBo Partners for Monthly Dual-Action Diabetes Drug Development
PremiumCompany Announcements
NeuroBo Partners for Monthly Dual-Action Diabetes Drug Development
3M ago
8K
NRBO
NeuroBo Pharmaceuticals signs research agreement for obesity treatment
PremiumThe Fly
NeuroBo Pharmaceuticals signs research agreement for obesity treatment
3M ago
NRBO
NeuroBo Pharmaceuticals Strikes Licensing Deal for NB-01
PremiumCompany Announcements
NeuroBo Pharmaceuticals Strikes Licensing Deal for NB-01
3M ago
8K
NRBO
NeuroBo Pharmaceuticals announces license agreement with MThera Pharma
PremiumThe FlyNeuroBo Pharmaceuticals announces license agreement with MThera Pharma
3M ago
NRBO
NeuroBo Pharmaceuticals files to sell 17.18M shares of common stock for holders
Premium
The Fly
NeuroBo Pharmaceuticals files to sell 17.18M shares of common stock for holders
4M ago
NRBO
NeuroBo Pharmaceuticals Releases Corporate Presentation Update
Premium
Company Announcements
NeuroBo Pharmaceuticals Releases Corporate Presentation Update
4M ago
8K
NRBO
NeuroBo Pharmaceuticals doses first patient in MAD Part 2 of DA-1726 trial
PremiumThe Fly
NeuroBo Pharmaceuticals doses first patient in MAD Part 2 of DA-1726 trial
5M ago
NRBO
NeuroBo Pharmaceuticals to sell 4.33M shares at $3.93 in private placement
PremiumThe Fly
NeuroBo Pharmaceuticals to sell 4.33M shares at $3.93 in private placement
5M ago
NRBO
NeuroBo Pharmaceuticals’ DA-1726 demonstrates ‘superiority in weight loss’
PremiumThe Fly
NeuroBo Pharmaceuticals’ DA-1726 demonstrates ‘superiority in weight loss’
5M ago
NRBO
NeuroBo Pharmaceuticals Enhances Equity Plan and Elects Directors
PremiumCompany Announcements
NeuroBo Pharmaceuticals Enhances Equity Plan and Elects Directors
5M ago
8K
NRBO
NeuroBo to report pre-clinical data on DA-1241 at EASL Congress 2024
PremiumThe FlyNeuroBo to report pre-clinical data on DA-1241 at EASL Congress 2024
6M ago
NRBO
NeuroBo Pharmaceuticals announces upcoming anticipated milestones
Premium
The Fly
NeuroBo Pharmaceuticals announces upcoming anticipated milestones
6M ago
NRBO
NeuroBo Pharmaceuticals reports Q1 EPS ($1.32) vs (51c) last year
Premium
The Fly
NeuroBo Pharmaceuticals reports Q1 EPS ($1.32) vs (51c) last year
6M ago
NRBO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >